Semaglutide for Weight Loss in Pembroke Pines: GLP-1 Guide
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist. GLP-1 stands for glucagon-like peptide-1, a hormone pathway involved in appetite, digestion and blood-sugar regulation. Semaglutide is the generic medication name. Brand names include Wegovy, which is FDA-approved for chronic weight management in eligible patients, and Ozempic, which is FDA-approved for type 2 diabetes and may also affect body weight. A medical evaluation helps determine which treatment, if any, is appropriate.
How GLP-1 treatment may support weight management
GLP-1 medications can increase feelings of fullness and reduce appetite, which may make it easier for some patients to follow a reduced-calorie nutrition plan. Medication is not a substitute for nutrition, activity, sleep and follow-up care. Results vary, and treatment should be individualized based on medical history, current medications and weight-related goals.
What to expect at SoFlo Medical Center
At SoFlo Medical Center, patients can discuss medically supervised weight-loss options at our Pembroke Pines and Miami Gardens locations. Your provider reviews your health history, goals, contraindications and appropriate monitoring before recommending a plan. Follow-up visits help assess tolerance, progress and next steps.
Safety matters
Semaglutide can cause side effects, including gastrointestinal symptoms, and is not appropriate for everyone. Prescription treatment requires a medical evaluation. Do not start, stop or change the dose of a prescription medication without guidance from a qualified healthcare professional.
Comments